• Tribunal upholds CMA’s decision to fine Lexon £1.2m pharmatimes
    March 02, 2021
    The Competition Appeal Tribunal (CAT) has maintained a decision made last year by the UK’s Competition and Markets Authority (CMA) to fine pharmaceutical firm Lexon £1.2m after finding the company guilty of breaking competition law.
PharmaSources Customer Service